During the past decade, Saga University Hospital conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 3 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 2 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saga University Hospital" #1 sponsor was "Pfizer" with 3 trials, followed by "Arena Pharmaceuticals" with 2 trials sponsored, "Astex Pharmaceuticals, Inc." with 2 trials sponsored, "Takeda" with 2 trials sponsored and "Daiichi Sankyo Co., Ltd." with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saga University Hospital" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 3 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Japan Clinical Oncology Group" with 1 trials as a collaborator, "Novo Nordisk A/S" with 1 trials as a collaborator and "OrbusNeich Medical K.K." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Saga University Hospital" are "Crohn's Disease" (4 trials), "Ulcerative Colitis" (4 trials), "Acute Myeloid Leukemia" (2 trials), "Adult T-cell Leukemia/Lymphoma" (1 trials) and "Alport Syndrome" (1 trials). Many other conditions were trialed in "Saga University Hospital" in a lesser frequency.

Most popular intervention types in "Saga University Hospital" are "Drug" (14 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Etrasimod" (5 trials), "Bardoxolone methyl" (1 trials), "Bevacizumab" (1 trials) and "Cilofexor (CILO)/Firsocostat (FIR)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Saga University Hospital" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Saga University Hospital". undefined are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Saga University Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Saga University Hospital, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".